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Summary
Introduction: Surgical site infections (SSI) are the most
common hospital-acquired infections among surgical pa-
tients, with significant impact on patient morbidity and
health care costs. The Basel SSI Cohort Study was per-
formed to evaluate risk factors and validate current pre-
ventive measures for SSI. The objective of the present art-
icle was to review the main results of this study and its
implications for clinical practice and future research.
Summary of methods of the Basel SSI Cohort Study: The
prospective observational cohort study included 6,283 con-
secutive general surgery procedures closely monitored for
evidence of SSI up to 1 year after surgery. The dataset
was analysed for the influence of various potential SSI risk
factors, including timing of surgical antimicrobial prophy-
laxis (SAP), glove perforation, anaemia, transfusion and
tutorial assistance, using multiple logistic regression ana-
lyses. In addition, post hoc analyses were performed to
assess the economic burden of SSI, the efficiency of the
clinical SSI surveillance system, and the spectrum of SSI-
causing pathogens.
Review of main results of the Basel SSI Cohort Study: The
overall SSI rate was 4.7% (293/6,283). While SAP was ad-
ministered in most patients between 44 and 0 minutes be-
fore surgical incision, the lowest risk of SSI was recor-
ded when the antibiotics were administered between 74 and
30 minutes before surgery. Glove perforation in the ab-
sence of SAP increased the risk of SSI (OR 2.0; CI 1.4–2.8;
p <0.001). No significant association was found for an-
aemia, transfusion and tutorial assistance with the risk of
SSI. The mean additional hospital cost in the event of SSI
was CHF 19,638 (95% CI, 8,492–30,784). The surgical
staff documented only 49% of in-hospital SSI; the infec-
tion control team registered the remaining 51%. Staphylo-
coccus aureus was the most common SSI-causing pathogen
(29% of all SSI with documented microbiology). No case
of an antimicrobial-resistant pathogen was identified in this
series.
Conclusions: The Basel SSI Cohort Study suggested that
SAP should be administered between 74 and 30 minutes
before surgery. Due to the observational nature of these
data, corroboration is planned in a randomized controlled
trial, which is supported by the Swiss National Science
Foundation. Routine change of gloves or double gloving
is recommended in the absence of SAP. Anaemia, trans-
fusion and tutorial assistance do not increase the risk of
SSI. The substantial economic burden of in-hospital SSI
has been confirmed. SSI surveillance by the surgical staff
detected only half of all in-hospital SSI, which prompted
the introduction of an electronic SSI surveillance system at
the University Hospital of Basel and the Cantonal Hospital
of Aarau. Due to the absence of multiresistant SSI-causing
pathogens, the continuous use of single-shot single-drug
SAP with cefuroxime (plus metronidazole in colorectal
surgery) has been validated.
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Introduction
Surgical site infections (SSI) account for 14–16% of all
nosocomial infections in inpatients and are considered the
most common nosocomial infection among surgical pa-
tients [1]. The direct and indirect costs of treating SSI can
be extremely high [2]. SSI are considered to reflect the
quality of care, as they are potentially preventable complic-
ations directly linked to surgery.
The issue of risk factors and prevention measures for SSI
has not been studied as thoroughly or as systematically
as one would like, mostly for ethical or logistical reasons.
Thus, many of the current recommendations of the Centres
for Disease Control and Prevention (CDC) are based on a
strong theoretical rationale or suggestive evidence in the
absence of confirmatory scientific knowledge [1]. To ad-
dress this problem, the Department of Surgery and the Di-
vision of Infectious Diseases and Hospital Epidemiology
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 1 of 9
at the University Hospital of Basel followed a large pro-
spective observational series of surgical patients closely for
evidence of SSI, and then analysed the dataset for the influ-
ence of various risk factors.
It is hoped that this review of the Basel SSI Cohort Study
further stimulates surgeons, operating room nurses, post-
operative inpatient and clinic nurses, infection control pro-
fessionals, anaesthesiologists and healthcare epidemiolo-
gists to engage actively in surgical research for the preven-
tion of SSI.
Areas of interest and review of the
literature
Timing of surgical antimicrobial prophylaxis [3]
The use of routine surgical antimicrobial prophylaxis
(SAP) was a breakthrough in the prevention of SSI [4].
Today, single-shot administration of first- or second-gener-
ation cephalosporin is the state-of-the-art procedure in SAP
in non-clean surgical interventions and implant surgery [5].
Because anaerobic activity is limited in most cephalospor-
ins, treatment is supplemented with metronidazole in
colorectal surgery.
In 1961, Burke [6] showed in animals that the timing of
SAP was crucial. The [7] observational landmark paper of
Classen et al. determined that in humans, the antimicrobi-
al agent should be administered within 2 hours before sur-
gery. The guidelines for prophylactic administration of ce-
furoxime (a second-generation cephalosporin), combined
with metronidazole in colorectal surgery, were based on
this time window at the University Hospital of Basel during
the study period. Other authors [8, 9] have suggested that
the optimal window for SAP is less than 60 minutes before
skin incision, or have simply advised performing SAP im-
mediately prior to the incision. Therefore, current
guidelines recommend conducting SAP 60 minutes or less
before surgery [4, 10].
Administration of SAP less than 30 minutes before incision
has been routine practice at the University Hospital of
Basel. However, there is little evidence in the literature
to show that tissue levels of cefuroxime can within just a
few minutes reach the minimum inhibitory concentration
at incision required to prevent SSI. Administration of SAP
within the final half hour before surgery may be too late for
optimal prevention of SSI.
Therefore, the Basel SSI Cohort Study was designed
primarily with emphasis on the influence of the timing of
SAP on the incidence of SSI [3].
Surgical glove perforation and the risk of surgical site
infection [11]
Pathogens may be transferred both from the surgical team
to patients [12, 13] and vice-versa [14]. Skin-borne patho-
gens on staff hands are particularly prone to transfer. Con-
sequently, all staff members wear surgical gloves as a pro-
tective barrier to prevent hand-wound contamination dur-
ing operations.
The risk of glove perforation increases with the duration of
surgery [15, 16]. The factors causing glove perforation in-
clude puncture by needles and sharp surfaces on complex
instruments [17, 18]. The frequency of glove perforation
during surgery has been repeatedly studied and found to
range from 8 to 50% [16, 19–24]. However, the impact of
glove perforation on the risk of SSI has been unknown.
The second analysis of the Basel SSI Cohort Study was
conducted to test the hypothesis that clinically visible sur-
gical glove perforation is associated with an increased SSI
risk.
The association of preoperative anaemia and
perioperative allogeneic blood transfusion with the risk
of surgical site infection [25]
The association of blood transfusion with the risk of SSI re-
mains controversial. While many observational series sug-
gested that blood transfusion was a risk factor for the devel-
opment of SSI [26–33], others achieved contradictory res-
ults [34–36]. Several randomised controlled trials (RCT)
investigated the relationship between the use of different
types of blood transfusion and overall infectious complic-
ation rates among different surgical specialities [37–41].
However, the results of investigations into whether receiv-
ing versus not receiving blood transfusion is associated
with infection after surgery were observational in nature
and susceptible to confounding. Interpretation of previ-
ously published studies is difficult due to inconsistencies in
the types of blood components and the timings of transfu-
sions, and consideration of all possible confounding factors
[1, 42, 43].
The primary objective of this analysis of the Basel SSI Co-
hort Study was to investigate the association of perioper-
ative allogeneic blood transfusion (ABT) with the risk of
SSI. Moreover, as perioperative ABT is mainly performed
in patients with preoperative anaemia [34, 44, 45], we as-
sessed whether preoperative anaemia was associated with
the rate of SSI. Specifically, we hypothesised that periop-
erative ABT and preoperative anaemia increase the risk of
SSI.
Impact of surgical training on incidence of surgical site
infections [46]
Surgical skills are acquired primarily in the operating
room. According to William Halsted’s apprenticeship mod-
el (“see one, do one, teach one”), surgical training starts by
observing and then continues by taking an increasingly act-
ive role in the procedure [47]. Recently, various alternative
methods for teaching surgical techniques have been deve-
loped, such as box model or virtual reality simulation [48].
However, tutorial assistance during surgery continues to be
crucial to acquire a full command of surgical skills. This
training system can only be justified if it does not increase
the complication rate.
The purpose of this analysis of the Basel SSI Cohort Study
was to assess whether tutorial training in the operating
room leads to a higher incidence of SSI compared with sur-
gery performed autonomously by board-certified surgeons.
Economic burden of surgical site infections at a
European university hospital [49]
Many studies have demonstrated a direct economic impact
of SSI on health systems and an indirect impact on patients
[50–55]. However, the magnitude of the economic SSI-re-
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lated burden differed across the studies, mainly because of
differences in healthcare reimbursement systems, the meth-
odology of the surveillance, and the heterogeneity of the
complications [56]. The available information is difficult to
apply to any specific setting such as the University Hospit-
al of Basel. We therefore conducted a matched case-control
study nested in the prospective observational Basel SSI Co-
hort Study to quantify the economic and medical burden of
SSI at the University Hospital of Basel.
Surveillance of surgical site infections by surgeons:
biased underreporting or useful epidemiological data?
[57]
SSI surveillance involving a feedback from the infection
control personnel to surgeons has been shown to reduce
the incidence of SSI by >30% [58]. However, this sort of
surveillance is time-consuming and expensive. Other meth-
ods of surveillance have been described that economise re-
sources and optimise sensitivity [59, 60]. One possible ap-
proach is self-assessment by the surgical team before the
patient is discharged. However, this simple and low cost
approach has been questioned in terms of sensitivity and
accuracy of data, due to the significant risk of underreport-
ing [61, 62].
The aim of this analysis by the Basel SSI Cohort Study
was to determine the quality of in-house SSI surveillance
by surgeons during the study period compared with surveil-
lance performed by an infection control team.
Spectrum of pathogens in surgical site infections at a
Swiss university hospital [63]
The type of SAP is determined by the spectrum and an-
timicrobial resistance of pathogens causing SSI. Continu-
ous efforts to identify outbreaks of antimicrobial-resistant
pathogens are therefore mandatory. The present study was
conducted to describe the epidemiologic features of SSI at
the University Hospital of Basel and to outline their micro-
biological patterns, including antimicrobial resistance.
Summary of methods of the Basel SSI
Cohort Study
The Basel SSI cohort study was part of a quality improve-
ment programme at Basel University Hospital. It was sup-
ported by the hospital executive board and approved by the
local research ethics committee. A total of 6,283 consecut-
ive surgeries, performed between 1 January 2000, and 31
December 2001 in the visceral, vascular, and trauma divi-
sions were evaluated.
The outcome of interest was SSI according to CDC criteria.
The surgical resident prospectively completed a paper-
based surveillance form for each patient, including the type
of SSI, date of diagnosis and treatment. Each form was
cross-checked and signed by an attending surgeon. Follow-
up after discharge was assessed by reviewing outpatient
charts and by contacting family practitioners who per-
formed the clinical checks after surgery. Where data were
missing, study team physicians interviewed patients by
telephone pursuant to a standardised questionnaire. An in-
fectious disease specialist confirmed all SSI by compre-
hensive review of patient history, initial microbiology res-
ults and outcome >1 year after surgery.
More than eighty patient and procedure variables were re-
corded, including age, sex, American Society of Anaes-
thesiologists (ASA) score, type of procedure, surgical team
members, division of surgical speciality, timing of SAP,
wound class, duration of surgery, compromised asepsis,
and many other known and suspected SSI risk factors. We
used an electronically readable form created by Cardiff
TELEForm Software (Cardiff TELEForm Desktop V 8.0,
2002, Verity Inc., Sunnyvale, CA) to export the data into an
Excel file (Windows Microsoft Excel 2003, Microsoft Cor-
poration).
Specific methods
The primary predictor variable of the first analysis was
SAP timing. We divided time into intervals, and chose the
cutoffs of 120 and 0 minutes before surgery on the basis of
the findings of Classen et al. [7]. SAP was administered in-
travenously by the anaesthetists via single-shot infusion of
1.5 g cefuroxime in 20 ml sodium chloride solution over a
few minutes in combination with metronidazole (500 mg,
intravenous, 5 minutes) in colorectal patients. The exact
time in minutes when the infusion of SAP ended was pro-
spectively recorded by the anaesthesia team.
The main predictor variable of the second analysis was
compromised asepsis due to glove perforation. The oper-
ating room nurse was responsible for the detection and
registration, either directly when glove perforation itself
was visible or indirectly when liquid was detected inside a
glove. When double gloves were used, leakage of the inner
glove was noted.
The main predictor variables of the third analysis were
perioperative ABT and preoperative anaemia. Perioperat-
ive ABT was performed by the anesthesia team in the op-
erating room. The number of allogeneic blood units was
monitored. All blood donations were leukocyte-depleted
(leukocytes <1.0 × 106/unit) by specific filtration (Optipure
RZ 2000 filters, Baxter) and plasma was removed. Packed
red cells were stored in saline-adenine-glucose-mannitol at
4 °C. Preoperative anaemia was defined as <120 g/l haemo-
globin.
For analysis of the impact of surgical training on the in-
cidence of SSI, surgeries were divided into two groups: tu-
torial assistance or autonomous surgery. Tutorial assistance
was defined as surgical training of a resident by a board-
certified surgeon, or operations conducted by an inexperi-
enced general surgeon supervised by a board-certified sur-
geon with extensive expertise in the field.
For analysis of the economic burden of in-hospital SSI,
the outcome variables were total duration of hospitalisa-
tion, duration of hospitalisation after surgery, duration of
intensive care stay after surgery, duration of in-hospital use
of antibiotics, patient charges and hospital costs. Since the
collection of cost data was not part of the observational co-
hort study design, this information was derived from the
hospital’s finance department. Their computerised internal
cost and activity accounting database directly linked intern-
al hospital costs with patient charges. Control patients had
no SSI and were matched to case patients by age, proced-
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ure code, and National Nosocomial Infection Surveillance
(NNIS) risk index.
To assess the quality of in-house SSI surveillance by sur-
geons during the study period, an infection control team
(ICT) evaluated all general surgery patients by full chart re-
view and by gathering additional clinical information. Data
from the surgeons’ surveillance system were available for
the ICT. The ICT consisted of a board certified infectious
diseases specialist and a hospital epidemiologist.
Microbiological evaluation consisted of microscopic direct
preparation and cultures with antibiotic resistance testing.
As superficial wound swabbing is difficult to interpret, the
decision to treat superficial SSI with antibiotics was made
clinically rather than on the basis of the results of a wound
swab.
Statistical analyses
All analyses were conducted at the Institute of Social and
Preventive Medicine in Bern using Stata version 9.2 as well
as version 10 (Stata Statistical Software; Stata Corp., Col-
lege Station, TX). In the first step, univariable analyses
were performed to assess the association between the
primary predictor variable and the unadjusted likelihood
of SSI occurrence. Then multivariable logistic regression
models were used to examine the risk-adjusted association
between the primary predictor variable and the odds of con-
tracting SSI. The decision on what variables to include in
the regression model was based on their potential role as
SSI risk factors or on indications of differences in distri-
bution. Crude and adjusted odds ratios (OR), 95% confid-
ence intervals (CI), and P values were used to express the
strength of this association. All P values were two-sided
and statistical significance was set at the 0.05 level.
Review of results of the Basel SSI
Cohort Study
The total study population consisted of 6,283 procedures
in 4808 patients with full in-hospital data records. A long-
term follow-up after discharge was achieved for 5,721 of
these 6,283 procedures (91.1%).
A summary of the adjusted odds ratios from multivariable
analyses of contracting surgical site infection by occur-
rence of the potential risk factors under study is given in
table 1.
The timing of surgical antimicrobial prophylaxis [3]
SAP was applied in 4,265 of the 6,283 procedures and ad-
ministered within 2 hours before incision in 3,836 proced-
ures. These 3,836 procedures met the inclusion
criteria for this analysis and were performed in 3,313 pa-
tients with a median hospital stay of 10 days (interquartile
range 6–17 days). A total of 180 SSI were detected (4.7%),
in 109 instances during inpatient and in 71 instances during
outpatient follow-up.
SAP was applied in most patients between 44 and 0
minutes before surgical incision. The lowest risk of SSI,
however, was recorded when the antibiotics were admin-
istered between 74 and 30 minutes before surgery (fig. 1).
Univariable logistic regression analysis showed that when
antibiotic prophylaxis was applied 29 to 15 (unadjusted OR
= 2.96; 95% CI 1.6 to 5.5; p = 0.001) and 14 to 0 (unad-
justed OR = 1.99; 95% CI 1.0 to 3.8; p = 0.041) or 120 to
75 minutes prior to surgery (unadjusted OR = 3.25; 95%
CI 1.5 to 7.1; p = 0.003) , the likelihood of SSI was signi-
ficantly higher than when the antibiotics were administered
between 59 and 45 minutes prior to surgery. The hetero-
Figure 1
Risk of surgical site infection by timing of surgical antimicrobial
prophylaxis. The lowest risk of surgical site infection was observed
when the antibiotics were administered between 74 and 30 minutes
before surgery.
Table 1: Adjusted odds ratio of contracting surgical site infection by occurrence of potential risk factors in multivariable analyses.
Characteristics Adjusted odds ratio 95% CI p-value
–59 to –45 min before incision 1 Reference
–29 to –15 min before incision 2.82 1.5–5.3 0.001
Timing of SAP*
–120 to –75 min before incision 3.16 1.4–7.0 0.005
No 1 ReferenceWith SAP*




Yes 4.24 1.7 to 10.8 0.003
No 1 Reference
Yes: 1–2 units 1.25 0.8–1.9 0.310
Allogeneic blood transfusion
Yes: ≥3 units 1.07 0.6–2.0 0.817
No 1 ReferencePreoperative anaemia
Yes 0.91 0.7–1.2 0.530
No 1 ReferenceSurgical training
Yes 0.82 0.62–1.09 0.163
*SAP = surgical antimicrobial prophylaxis.
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geneity of SSI risk with timing of SAP remained statist-
ically significant after adjusting for twelve confounders in
multivariable analyses (p-value from likelihood ratio test
= 0.0002). In addition, these analyses confirmed various
known SSI risk factors, such as ASA score, wound class,
duration of surgery, smoking status, diabetes and intraoper-
ative hypothermia.
Surgical glove perforation [11]
For analysis of the impact of compromised asepsis on oc-
currence of SSI, 747 of the 6,283 procedures (12%) were
excluded due to highly contaminated CDC wound class 4.
In 1,389 cases (22%) the presence or absence of glove per-
foration during surgery was not recorded. The remaining
4,147 procedures, with a total of 188 SSI (4.5%), were ac-
cepted for this analysis.
Glove perforation was recorded in 677 interventions
(16.3%). After these procedures, 51 SSI (7.5%) were re-
corded, compared to 137 SSI (3.9%) in 3,470 procedures
where asepsis was not breached (crude OR = 1.98; 95% CI,
1.4–2.8; p <0.001). Multivariable logistic regression ana-
lyses showed that the increase of SSI likelihood with glove
perforation differed between procedures with and without
SAP (test for effect-modification: p = 0.005). SAP was giv-
en in 3,233 interventions, and glove perforations were de-
tected in 605 of the 3,233 operations (18.7%). Multivari-
able logistic regression analysis showed that in procedures
with SAP the odds of contracting SSI in the event of glove
puncture were not significantly higher than when gloves re-
mained intact (adjusted OR = 1.25; 95% CI 0.85 to 1.85; p
= 0.263). In the absence of SAP (n = 914), however, glove
leakage was associated with an SSI rate of 12.7%, as op-
posed to 2.9% where asepsis was not compromised. This
difference was statistically significant in both univariable
(OR = 4.9; 95% CI 2.2 to 11.0; p <0.001) and multivariable
(OR = 4.24; 95% CI 1.7 to 10.8; p = 0.003) analysis.
Preoperative anaemia and perioperative allogeneic
blood transfusion (25)
This analysis included 5,873 procedures with 284 SSI
(4.8%). Univariable analysis showed significant associ-
ations between anaemia or blood transfusion and risk of
SSI. After including duration of surgery as confounder in
multivariate analysis, these associations disappeared (an-
aemia: OR, 0.91; 95% CI 0.7 to 1.2; p = 0.53 / transfusion:
OR, 1.07; 95% CI 0.6 to 2.0; p = 0.817).
Surgical training [46]
This analysis included 6,103 procedures and 290 SSI
(4.8%). Surgery was performed with tutorial assistance in
39% (2,388/6,103) and autonomously in 61% (n = 3,715/
6,103). Surprisingly, univariable analysis showed a signi-
ficant increase in the rate of SSI for autonomously per-
formed procedures compared to those under supervision
(5.4% vs 3.8%; OR = 0.70; 95% CI 0.543–0.902;
p = 0.006). However, this association did not remain signi-
ficant after adjusting for confounders in multivariable ana-
lysis (OR = 0.82; 95% CI 0.62–1.09; p = 0.163).
Economic impact of surgical site infections [49]
For this matched case-control study, 183 case patients with
in-hospital SSI were primarily considered and 168 (92%)
were successfully matched to a suitable control patient.
In the event of SSI, the mean additional hospital cost was
CHF 19,638 (95% CI CHF 8,492–30,784). The mean post-
operative length of hospitalisation for case patients was
more than double that for control patients (29.0 vs 12.3
days; p = .001), resulting in a mean additional postoperat-
ive hospital stay of 16.8 days (95% CI, 13–20.6 days). The
mean duration of additional in-hospital antibiotic therapy
was 7.4 days (95% CI 5.1–9.6). Logistic regression ana-
lyses showed significantly higher odds of antibiotic ther-
apy for patients with SSI (OR = 3.23; 95% CI 2.0– 5.2; p
= .001). The overall mean increase in SSI-related hospital
costs was 60.6%
Surveillance of surgical site infections by surgeons [57]
This analysis included 6,283 procedures and 187 in-hospit-
al SSI. The surgical staff documented only 91/187 (48.7%)
of in-hospital SSI, while the ICT registered the remaining
96/187 (51.3%). By division, the visceral surgeons doc-
umented 59/105 (56.2%), the vascular surgeons 14/37
(37.8%) and the trauma surgeons 18/45 (40.0%) in-hospital
SSI.
Spectrum of pathogens [63]
Microbiological evaluation has not been performed or was
not conclusive in 164 of 293 SSI (56%). The germ spec-
trum in the remaining 129 SSI (44%) identified not a single
case of methicillin-resistant Staphylococcus aureus
(MRSA) or other bacteria with increased antimicrobial res-
istance. Staphylococcus aureus was the most common SSI-
causing pathogen in trauma and vascular surgery, whereas
Escherichia coli was more frequently found in SSI after
visceral surgery. Overall, Staphylococcus aureus was the
most common SSI-causing pathogen (29% of all SSI with
documented microbiology).
Discussion
The prospective observational Basel SSI Cohort Study of
6,283 procedures performed on 4,808 patients allowed us
to investigate several a priori and post hoc hypotheses. Ad-
ministration of SAP within the final half hour versus ad-
ministration at earlier points in time before surgery and
glove perforation in the absence of SAP have been iden-
tified as significant independent risk factors for SSI. An-
aemia, transfusion and tutorial assistance did not increase
the risk of SSI. The substantial economic burden of in-hos-
pital SSI has been confirmed. SSI surveillance by the sur-
gical staff detected only half of all in-hospital SSI. Due
to the absence of multiresistant SSI-causing pathogens, the
continuous use of single-shot single-drug SAP with cefur-
oxime (plus metronidazole in colorectal surgery) has been
validated.
The a priori hypothesis proved to be true inasmuch as ad-
ministration of SAP within the final half hour before sur-
gery may be too late for optimal prevention of SSI. Im-
portantly, healthcare providers in the United States and in
Europe often fail to meet the present broad recommenda-
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tion to get drugs started during the 60-minute window be-
fore surgery [4, 5, 64]. Further constricting that time win-
dow and requiring that the infusion should be completed
30 minutes before incision may make this target even more
difficult. Nonetheless, SAP has been delivered during the
hour before incision >90% of the time during the study
period, and the goal should be to apply SAP at the optimal
time, despite all difficulties. Hence the guidelines in place
at the University Hospital of Basel now demand that SAP
be completed 30 minutes before the start of surgery.
However, two large prospective studies observed the low-
est risk of SSI when SAP was given within 30 minutes
prior to incision [65, 66]. Therefore, current international
guidelines for the correct timing of SAP are based on ob-
servational studies, which have recently achieved discord-
ant results. A well conducted RCT seems warranted to
obtain a clear answer on the optimal timing. We plan to
conduct a bicentre prospective RCT at two tertiary referral
centers in Switzerland, the University Hospital of Basel
and the Cantonal Hospital of Aarau. The study is supported
by the Swiss National Science Foundation. This RCT will
compare two different delivery modi for SAP, which will
result in different average administration times: SAP deliv-
ery in the anaesthesia room (more than 30 minutes before
incision) vs SAP delivery in the operating room (less than
30 minutes before incision). We hypothesise that the rate of
SSI is significantly lower with administration of SAP more
than 30 minutes before the scheduled incision as compared
with less than 30 minutes before the scheduled incision. We
plan to include 5,000 patients undergoing visceral, vascular
and trauma procedures – 2,500 per treatment arm – and as-
sess the occurrence of SSI during a 30 day follow-up peri-
od (1 year if an implant is in place). We expect the study to
be completed within 3 years.
While various studies have assessed the frequency of glove
perforation, the relevant consequences in terms of SSI risk
have been largely neglected. The second analysis showed
that in the absence of SAP glove perforation increased the
risk of SSI. Efforts to decrease the frequency of glove per-
foration in procedures without SAP, such as double gloving
or routinely changing gloves in longer surgical procedures,
are therefore encouraged as the first line of SSI preven-
tion. These measures are effective and safe. However, im-
plementing them in clinical practice can be difficult. Al-
ternatively, the indication for SAP may be broadened to all
surgical procedures. SAP has been shown to prevent SSI
after clean surgery in several RCT [67–69], but there is no
current consensus regarding its use in this area. The present
results theoretically support an extended indication of SAP
to all clean procedures when no strict precautions are taken
to prevent glove perforation. However, the advantages of
generalised SAP administration must be balanced against
the adverse effects of the prophylactic antibiotics, such as
increased costs, drug reactions and, most importantly, bac-
terial resistance.
The results of the third analysis strengthen existing doubts
on the role of transfusion of leukocyte-depleted packed
red cells during surgery and preoperative anaemia as risk
factors for SSI. No significant relationship could be found
after including duration of surgery in the multivariable
model, which was found to be the most important con-
founder, presumably as a surrogate for the complexity of
the patients and procedures. This underlines the role of co-
variate selection in the statistical analyses conducted on
this topic, which may help to explain the disagreement
among the published observational studies [42, 43].
Surgical training did not result in higher infection rates in
this study. Therefore, while other forms of training are use-
ful, tutorial assistance in the operating room continues to
be the mainstay of surgical education at our hospitals.
The matched case-control study confirmed the substantial
economic impact of in-hospital SSI and provided an estim-
ate of the resources that may be saved by reducing the SSI-
related heavy burden on patients and healthcare providers.
Hence, future research in this field has the potential to be-
come a matter of significant interest in terms of national
and international healthcare economics.
The SSI surveillance system used by the surgical staff dur-
ing the study period detected only half of all in-hospital
SSI. This documented poor performance called for a major
revision of the procedures to ascertain in-hospital SSI. The
main procedural problem identified was that the resident
had to complete a paper form to register SSI when he pre-
pared all the discharge documents, a time of considerable
time pressure, which resulted in many missed (i.e. non-re-
gistered) infections mostly in patients on a longer hospit-
al stay. Therefore, substantial efforts have been undertaken
to develop an electronic SSI surveillance system, which
has recently been introduced at the University Hospital of
Basel and the Cantonal Hospital of Aarau. It allows resid-
ents to prospectively register detailed information on SSI
in much less time compared with the old system. Further-
more, surveillance is now a continuous procedure, allow-
ing registration of events immediately after diagnosis, for
example after the resident’s round with an attending sur-
geon. When the patient is discharged, the resident reviews
all the information on patients’ hospital course and then
presses the save button on the electronic surveillance form.
This creates an E-mail to the attending surgeon in charge
of the patient asking him to confirm the findings. The elec-
tronic SSI surveillance system is much more user-friendly
compared with the former version. The system generates
a weekly reminder E-mail to the attending surgeons in-
cluding a list of their patients with missing information on
wound surveillance after discharge. In addition, it allows
the attending surgeons to continuously control surveillance
by residents with a detailed list on the intranet.
The spectrum of SSI-causing pathogens identified and the
very low incidence of antimicrobial resistance at the
University Hospital Basel validate the continuous use of
single shot single-drug SAP with cefuroxime (plus met-
ronidazole in colorectal surgery).
By way of summary, current guidelines for SSI prevention
have been evaluated in various ways, and future research
projects in this field have been defined. We hope that the
combined efforts of the University Hospital of Basel and
the Cantonal Hospital of Aarau will translate in a signific-
ant reduction of SSI rates, corresponding costs and provi-
sion of specialised care.
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Figures (large format)
Figure 1
Risk of surgical site infection by timing of surgical antimicrobial prophylaxis. The lowest risk of surgical site infection was observed when the
antibiotics were administered between 74 and 30 minutes before surgery.
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